acetylcysteine has been researched along with Ambulation Disorders, Neurologic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, DA; Choi, S; Kong, L; Lutgen, V; Qualmann, K; Resch, J | 1 |
Khan, M; Pannu, R; Singh, AK; Singh, I; Won, JS | 1 |
2 other study(ies) available for acetylcysteine and Ambulation Disorders, Neurologic
Article | Year |
---|---|
Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc⁻ activity in the medial prefrontal cortex.
Topics: Acetylcysteine; Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Animals; Benzoates; Disease Models, Animal; Dose-Response Relationship, Drug; Gait Disorders, Neurologic; Glycine; In Situ Hybridization; Male; Phencyclidine; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Reflex, Startle; RNA, Messenger; Schizophrenia; Sensory Gating | 2013 |
A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases.
Topics: Acetylcysteine; Animals; Antigens, CD; Antioxidants; Apoptosis; Astrocytes; Cells, Cultured; Demyelinating Diseases; Drug Evaluation, Preclinical; Enzyme Induction; Enzyme Inhibitors; Fatty Acids; Female; Gait Disorders, Neurologic; Galactosyltransferases; I-kappa B Proteins; Inflammation; Interferon-gamma; Lactosylceramides; Lipopolysaccharides; Morpholines; Nerve Tissue Proteins; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidation-Reduction; Phosphorylation; Proline; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Signal Transduction; Spinal Cord Injuries; Thiocarbamates; Transfection | 2004 |